D-0075-2021 Class II Terminated
FDA drug recall D-0075-2021 was initiated by Zydus Pharmaceuticals (USA) Inc on Oct 27, 2020 and is designated Class II. Reason for recall: Failed Dissolution Specification The recall status is terminated (terminated Dec 20, 2022). Affected quantity: 7,908 units.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 11, 2020
- Initiation Date
- Oct 27, 2020
- Termination Date
- Dec 20, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 7,908 units
Product description
Lansoprazole Delayed-Release Orally Disintegrating Tablets 30 mg, 100-count carton (10 x10 unit-dose), Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534, NDC 68382-772-77
Reason for recall
Failed Dissolution Specification
Distribution pattern
Distributed Nationwide in the USA
Code information
Lot # M005682, EXP 3/2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0075-2021
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026